Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
New study suggests that modifying the gut microbiota could shape baseline immune states to improve infection resistance and responses to vaccines and immunotherapies.
Diet shapes probiotic colonization, offering strategies to improve colonization, modulate the microbiota, and control harmful microbes.
Monitoring shifts in microbial interaction networks could help to detect and track gut-related conditions.
Bacteria such as Enterococcus faecium and Limosilactobacillus reuteri are key in activating an immune receptor that boosts the activity of protective immune cells.
Targeting specific bacterial strains, rather than overall gut diversity, can help develop effective microbiota therapies.
In periodontitis, helpful gum bacteria become less active while harmful bacteria change their behavior to feed on available nutrients and worsen disease, suggesting new targeted treatment approaches.
Bacterial extracellular vesicles released by L. salivarius activate immune cells, boosting the effectiveness of immunotherapy in stomach cancer.
Uncultured gut bacteria, particularly one group called CAG-170, are key contributors to a healthy microbiota.
Bifidobacterium longum and B. infantis are distinct species with strains adapted to local diets, highlighting the importance of developing geographically tailored infant probiotics.
HMGB1 is a key protein that blocks bacterial adhesion and virulence, protecting intestinal cells and helping to maintain a healthy microbiota.
